CAH News and Press, Cardinal Health Inc. From 06/05/23

2023-06-05 13:46:22 ET Cardinal Health ( NYSE: CAH ) said it plans to merge its Outcomes digital health solutions business into Transaction Data Systems, or TDS, in exchange for a minority stake in the combined company. TDS is a provider of independent pharmacy management softwa...

Cardinal Health announces the merger of its Outcomes™ business into Transaction Data Systems and related partnership PR Newswire Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical phar...

2023-06-03 02:54:00 ET Summary May 2023 totaled $1,328.67 in dividend income for the month. Dividend increases from companies such as Leggett & Platt, LyondellBasell, and Broadstone Net Lease contributed to the growth in passive dividend income. In total, the dividend incr...

Cardinal Health launches Modern Commerce Solutions for Retail Independent Pharmacies powered by Square PR Newswire DUBLIN, Ohio and SAN FRANCISCO , May 31, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched modern payment solutions, power...

2023-05-30 01:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-05-24 23:46:39 ET Summary In the past year, Cardinal Health (CAH: +50.95%) has rallied significantly, with share price action superior to both the broad market (SPY: +5.51%) and the healthcare industry (IXHC: +12.81%). This reflects a 34.80% in free cash flow from 2021-22 to ...

2023-05-24 05:54:01 ET Summary Cardinal Health reported solid third quarter results and raised full-year guidance. In the last twelve months, Cardinal Health's stock outperformed as the stock price saw a reversion to the mean from previously extreme undervaluation. And while t...

2023-05-20 10:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-05-20 00:15:35 ET Summary SCPH's Furoscix, despite just launching, defied street consensus with an impressive $2.1M revenue in 1Q23, indicating a promising ramp trajectory. Witnessing a substantial increase in Furoscix's prescriptions and robust demand, supported by a growing...

2023-05-17 22:07:02 ET Summary I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process and comparing the results to NOBL and SCHD. Thus...